Quality of life in Wilson's disease

R. Komal Kumar, A. Taly, K. P S Nair, S. Sinha, L. Prashanth, N. Vidya, G. Arunodaya, S. Rao

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Background: Assessment of Quality of life (QoL) is fast assuming significance as the measure of health in many disorders. Aim: To correlate clinical severity and QoL in patients with Wilson's disease (WD). Materials and Methods: We evaluated patients of WD on regular follow up for at least two years and aged over 18 years using Neurological Symptom Score (NSS) for clinical severity and WHO-BREF for QoL at a university teaching hospital. Patients with inability to respond to the questionnaire due to behavioral problems, low IQ or other disease related factors were excluded. These 30 patients (M:F:: 23:7) had a mean age of 27.97 ± 11.16 years at evaluation and the mean duration of treatment of 9.2 ± 6.4 years. Results: All four domains of WHO-QoL-BREF viz., Physical, Psychological, Social and Environmental correlated well with each other ( p <0.01). The NSS correlated inversely with the physical domain ( p <0.02), while the duration of treatment had a positive correlation with the physical domain ( p <0.01). None of the other features of QoL showed any significant correlation with age, NSS or duration of treatment. Conclusion: QoL is complementary to formal neurological assessment and should be routinely incorporated in the evaluation of outcome of patients with WD and other chronic neurological disorders.

Original languageEnglish
Pages (from-to)37-43
Number of pages7
JournalAnnals of Indian Academy of Neurology
Volume11
Issue number1
Publication statusPublished - Jan 1 2008

Fingerprint

Hepatolenticular Degeneration
Quality of Life
Nervous System Diseases
Teaching Hospitals
Therapeutics
Psychology
Health

Keywords

  • Quality of life
  • WHO-BREF
  • Wilson's disease

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Komal Kumar, R., Taly, A., Nair, K. P. S., Sinha, S., Prashanth, L., Vidya, N., ... Rao, S. (2008). Quality of life in Wilson's disease. Annals of Indian Academy of Neurology, 11(1), 37-43.

Quality of life in Wilson's disease. / Komal Kumar, R.; Taly, A.; Nair, K. P S; Sinha, S.; Prashanth, L.; Vidya, N.; Arunodaya, G.; Rao, S.

In: Annals of Indian Academy of Neurology, Vol. 11, No. 1, 01.01.2008, p. 37-43.

Research output: Contribution to journalArticle

Komal Kumar, R, Taly, A, Nair, KPS, Sinha, S, Prashanth, L, Vidya, N, Arunodaya, G & Rao, S 2008, 'Quality of life in Wilson's disease', Annals of Indian Academy of Neurology, vol. 11, no. 1, pp. 37-43.
Komal Kumar R, Taly A, Nair KPS, Sinha S, Prashanth L, Vidya N et al. Quality of life in Wilson's disease. Annals of Indian Academy of Neurology. 2008 Jan 1;11(1):37-43.
Komal Kumar, R. ; Taly, A. ; Nair, K. P S ; Sinha, S. ; Prashanth, L. ; Vidya, N. ; Arunodaya, G. ; Rao, S. / Quality of life in Wilson's disease. In: Annals of Indian Academy of Neurology. 2008 ; Vol. 11, No. 1. pp. 37-43.
@article{111c1a8fab444025853efb6337f67f01,
title = "Quality of life in Wilson's disease",
abstract = "Background: Assessment of Quality of life (QoL) is fast assuming significance as the measure of health in many disorders. Aim: To correlate clinical severity and QoL in patients with Wilson's disease (WD). Materials and Methods: We evaluated patients of WD on regular follow up for at least two years and aged over 18 years using Neurological Symptom Score (NSS) for clinical severity and WHO-BREF for QoL at a university teaching hospital. Patients with inability to respond to the questionnaire due to behavioral problems, low IQ or other disease related factors were excluded. These 30 patients (M:F:: 23:7) had a mean age of 27.97 ± 11.16 years at evaluation and the mean duration of treatment of 9.2 ± 6.4 years. Results: All four domains of WHO-QoL-BREF viz., Physical, Psychological, Social and Environmental correlated well with each other ( p <0.01). The NSS correlated inversely with the physical domain ( p <0.02), while the duration of treatment had a positive correlation with the physical domain ( p <0.01). None of the other features of QoL showed any significant correlation with age, NSS or duration of treatment. Conclusion: QoL is complementary to formal neurological assessment and should be routinely incorporated in the evaluation of outcome of patients with WD and other chronic neurological disorders.",
keywords = "Quality of life, WHO-BREF, Wilson's disease",
author = "{Komal Kumar}, R. and A. Taly and Nair, {K. P S} and S. Sinha and L. Prashanth and N. Vidya and G. Arunodaya and S. Rao",
year = "2008",
month = "1",
day = "1",
language = "English",
volume = "11",
pages = "37--43",
journal = "Annals of Indian Academy of Neurology",
issn = "0972-2327",
publisher = "Medknow Publications and Media Pvt. Ltd",
number = "1",

}

TY - JOUR

T1 - Quality of life in Wilson's disease

AU - Komal Kumar, R.

AU - Taly, A.

AU - Nair, K. P S

AU - Sinha, S.

AU - Prashanth, L.

AU - Vidya, N.

AU - Arunodaya, G.

AU - Rao, S.

PY - 2008/1/1

Y1 - 2008/1/1

N2 - Background: Assessment of Quality of life (QoL) is fast assuming significance as the measure of health in many disorders. Aim: To correlate clinical severity and QoL in patients with Wilson's disease (WD). Materials and Methods: We evaluated patients of WD on regular follow up for at least two years and aged over 18 years using Neurological Symptom Score (NSS) for clinical severity and WHO-BREF for QoL at a university teaching hospital. Patients with inability to respond to the questionnaire due to behavioral problems, low IQ or other disease related factors were excluded. These 30 patients (M:F:: 23:7) had a mean age of 27.97 ± 11.16 years at evaluation and the mean duration of treatment of 9.2 ± 6.4 years. Results: All four domains of WHO-QoL-BREF viz., Physical, Psychological, Social and Environmental correlated well with each other ( p <0.01). The NSS correlated inversely with the physical domain ( p <0.02), while the duration of treatment had a positive correlation with the physical domain ( p <0.01). None of the other features of QoL showed any significant correlation with age, NSS or duration of treatment. Conclusion: QoL is complementary to formal neurological assessment and should be routinely incorporated in the evaluation of outcome of patients with WD and other chronic neurological disorders.

AB - Background: Assessment of Quality of life (QoL) is fast assuming significance as the measure of health in many disorders. Aim: To correlate clinical severity and QoL in patients with Wilson's disease (WD). Materials and Methods: We evaluated patients of WD on regular follow up for at least two years and aged over 18 years using Neurological Symptom Score (NSS) for clinical severity and WHO-BREF for QoL at a university teaching hospital. Patients with inability to respond to the questionnaire due to behavioral problems, low IQ or other disease related factors were excluded. These 30 patients (M:F:: 23:7) had a mean age of 27.97 ± 11.16 years at evaluation and the mean duration of treatment of 9.2 ± 6.4 years. Results: All four domains of WHO-QoL-BREF viz., Physical, Psychological, Social and Environmental correlated well with each other ( p <0.01). The NSS correlated inversely with the physical domain ( p <0.02), while the duration of treatment had a positive correlation with the physical domain ( p <0.01). None of the other features of QoL showed any significant correlation with age, NSS or duration of treatment. Conclusion: QoL is complementary to formal neurological assessment and should be routinely incorporated in the evaluation of outcome of patients with WD and other chronic neurological disorders.

KW - Quality of life

KW - WHO-BREF

KW - Wilson's disease

UR - http://www.scopus.com/inward/record.url?scp=42249094024&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=42249094024&partnerID=8YFLogxK

M3 - Article

VL - 11

SP - 37

EP - 43

JO - Annals of Indian Academy of Neurology

JF - Annals of Indian Academy of Neurology

SN - 0972-2327

IS - 1

ER -